Middle East & Africa Cell Therapy Market Size & Outlook

Name: Middle East & Africa Cell Therapy Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The cell therapy market in Middle East & Africa is expected to reach a projected revenue of US$ 177.8 million by 2030. A compound annual growth rate of 14.3% is expected of Middle East & Africa cell therapy market from 2024 to 2030.

Middle East & Africa cell therapy therapy type outlook (Revenue, USD million, 2018-2030)
- Allogeneic Therapies
  - Stem Cell Therapies
    - Hematopoietic Stem Cell Therapies
    - Mesenchymal Stem Cell Therapies
  - Non-stem Cell Therapies
    - Keratinocytes & Fibroblast-based Therapies
    - Others
- Autologous Therapies
  - Stem Cell Therapies
    - BM, Blood, & Umbilical Cord-derived Stem Cells
    - Adipose Derived Cells
    - Others
  - Non-stem Cell Therapies
    - T-Cell Therapies
      - CAR T Cell Therapy
      - T Cell Receptor (TCR)-based
    - Others
Middle East & Africa cell therapy therapeutic area outlook (Revenue, USD million, 2018-2030)
- Oncology
- Cardiovascular Disease (CVD)
- Musculoskeletal Disorders
- Dermatology
- Others

Middle East & Africa Cell Therapy Market Size & Outlook

Sign up - it's easy, and free!